Stay updated on LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.

Latest updates to the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows revision v3.6.6, replacing v3.6.5, indicating a small update to the page or system. No study details or content appear to be altered in this change.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new Nat Med 2026 publication entry by Lim et al. is added with full citation details, and the prior 'Online ahead of print' citation is removed.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, representing an internal version update.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page's revision tag updated from v3.6.3 to v3.6.4, indicating a minor release or maintenance update. No study content or data appear to be changed.SummaryDifference0.0%

- Check54 days agoChange DetectedPublications section added to the study record. It includes a PubMed-sourced citation for 'Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial' and a note that publications are automatically filled from PubMed.SummaryDifference0.2%

- Check69 days agoChange Detected- The page revision label was updated from v3.6.2 to v3.6.3, indicating a new revision of the page content. This reflects a minor metadata update and does not alter the study details displayed.SummaryDifference0.0%

Stay in the know with updates to LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.